Placebo Group: Clinical Trials

272 trials of Placebo Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

155 completed, 56 unknown, 19 recruiting, 18 not yet recruiting. 145 Not applicable, 50 Phase 2, 41 Phase 3, 26 Phase 4, 24 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable145Completed 91, Unknown 28, Not yet recruiting 10, Recruiting 9, Active not recruiting 5, Terminated 1, Withdrawn 1
Phase 250Completed 20, Unknown 10, Not yet recruiting 6, Recruiting 6, Terminated 5, Active not recruiting 2, Withdrawn 1
Phase 341Completed 20, Unknown 11, Not yet recruiting 3, Recruiting 3, Terminated 2, Withdrawn 2
Phase 426Completed 19, Unknown 5, Active not recruiting 1, Terminated 1
Phase 124Completed 13, Unknown 4, Active not recruiting 2, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1
Early Phase 12Completed 1, Recruiting 1

Follow Placebo Group: new trials by email Literature Review of Placebo Group trials Research Report on Placebo Group

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Perioperative Intravenous Lidocaine Infusion on Post-amputation Pain in Amputee Patients
Lidocaine Hydrochloride, Injectable, 0.9% normal saline - Amputation
Not applicableNot yet recruitingWest China Hospital2002026-10-012026-08-25
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Xingqi Daozhi Decoction, Placebo Group - Schizophrenia, Antipsychotic Drug
Phase 1 / Phase 2Not yet recruitingShanghai Mental Health Center462026-10-012026-08-17
The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
5-methyltetrahydrofolate (5-MTHF), placebo group - Nonalcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease (NAFLD)
Not applicableNot yet recruitingTabriz University of Medical Sciences442026-09-302026-07-31
Effects of Different Acupuncture Techniques on the Success Rate in Patients With Recurrent Implantation Failure
Placebo Group, acupuncture group 1, acupuncture group 2 - Implantation Failure
Not applicableNot yet recruitingCui Hong Zheng3122026-09-012026-08-26
Improvised Endobag vs Direct Gallbladder Extraction in Laparoscopic Cholecystectomy
Endobag, placebo group - Cholecystectomy, Laparoscopic, Cholelithiasis
Not applicableRecruitingRawal Institute of Health Sciences Islamabad1202026-08-302026-09-16
Sancai Fengsui Decoction for RTOM: A Multicenter RCT
Sancai Fengsui Decoction, Placebo Group - Radiation-Induced Oral Mucositis (RTOM), Head and Neck Cancer
Phase 2Not yet recruitingNanfang Hospital, Southern Medical University1262026-08-012026-07-09
Magnetic Ressonance Imaging of Temporomandibular Joint
Intervention Group, Placebo group - Temporomandibular Joint Dysfunction
Not applicableNot yet recruitingDaniela Ap. Biasotto-Gonzalez242026-08-012025-02-28
The Effects of Menthol and Cold Spray Applications on Thirst and Comfort in Bariatric Surgery
Menthol Group, Cold Spray Group, Placebo Group - Thirst in Bariatric Surgery Patients
Not applicableNot yet recruitingAtlas University1802026-07-302026-07-27
Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery
melatonin (Circadin ®) 0.2 mg/kg, melatonin (Circadin ®) 0.4 mg/kg, placebo group - Preoperative Anxiety
Not applicableRecruitingAl-Azhar University1202026-07-122026-01-06
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
H021 Enteric-coated Tablets Low-dose Group, H021 Enteric-coated Tablets High-dose Group, Placebo Group - Crohn's Disease
Phase 2Not yet recruitingJiangsu Carephar Pharmaceutical Co., Ltd.1562026-07-122026-06-30
Effect of Acupuncture on the Success Rate in Patients With Recurrent Implantation Failure
Placebo Group, Acupuncture group - Implantation Failure
Not applicableNot yet recruitingHuazhong University of Science and Technology2082026-06-302026-06-25
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
ABP-671 plus febuxostat Group 1, ABP-671 plus febuxostat Group 2, ABP-671 Group - Chronic Kidney Disease
Phase 2Not yet recruitingAtom Therapeutics Co., Ltd802026-06-302026-06-04
SG301-SC Injection Safety Study in Subjects With Primary ITP Patients
low dose group, high dose group, Placebo group - Primary Immune Thrombocytopenia
Phase 2RecruitingHangzhou Sumgen Biotech Co., Ltd.602026-06-112026-09-09
Theranovis Dental Gel in Patients With Gingivitis
theranovis dental gel group, Placebo group - Gingivitis, Oral Health Care
Not applicableNot yet recruitingMedical University of Graz202026-06-012026-06-11
Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis
Roflumilast 500 Mcg Oral Tablet, Placebo Group - Rheumatoid Arthritis, Rheumatoid Arthritis (RA)
Phase 2RecruitingHorus University502026-05-192026-06-08
Metformin and Alveolar Cleft
metformin group, placebo group - Alveolar Cleft
Phase 2Not yet recruitingFayoum University362026-05-012026-04-17
A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
Placebo group, JS1-1-01 low-dose group, JS1-1-01 high-dose group - Depression
Phase 2 / Phase 3Not yet recruitingTasly Pharmaceutical Group Co., Ltd1802026-04-302026-04-08
Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy
Anruikefen (Intravenous Bolus), Anruikefen (Intravenous Infusion), Placebo Group - Gastrectomy, Postoperative Analgesia
Phase 2RecruitingTianjin Medical University Cancer Institute and Hospital1142026-04-082026-09-22
A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg, ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg, SIB Group Sibus (Sibutramine) 15mg - Overweight, Obesity
Phase 3WithdrawnEurofarma Laboratorios S.A.2026-04-012025-12-18
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
LpD3.5, Placebo - Mild Cognitive Impairment (MCI), Cognition
Early Phase 1RecruitingUniversity of South Florida152026-03-032026-08-31

Showing 20 of 272. Sign in to see all of them.

Conditions studied

Pain (10)  ·  Obesity (9)  ·  Pain, Postoperative (9)  ·  Diabetes Mellitus, Type 2 (7)  ·  Overweight (6)  ·  Sarcopenia (6)  ·  COVID-19 (5)  ·  Hypertension (5)  ·  Anxiety Disorders (4)  ·  Depression (4)  ·  Fatigue (4)  ·  Inflammation (4)  ·  Renal Insufficiency, Chronic (4)  ·  Agnosia (3)  ·  Breast Neoplasms (3)

Sponsors

Pusan National University Yangsan Hospital (13)  ·  Tasly Pharmaceutical Group Co., Ltd (8)  ·  West China Hospital (6)  ·  Wecare Probiotics Co., Ltd. (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  University of Sao Paulo (4)  ·  Ain Shams University (3)  ·  CHU de Quebec-Universite Laval (3)  ·  Federal University of São Paulo (3)  ·  Shenzhen Salubris Pharmaceuticals Co., Ltd. (3)  ·  TCI Co., Ltd. (3)  ·  Universidad Europea de Madrid (3)  ·  Amway (China) R&D Center (2)  ·  Changchun BCHT Biotechnology Co. (2)  ·  Chulalongkorn University (2)

Countries

China (53)  ·  Brazil (30)  ·  United States (29)  ·  South Korea (21)  ·  Spain (19)  ·  Egypt (13)  ·  Turkey (Türkiye) (12)  ·  Taiwan (10)  ·  Canada (9)  ·  France (8)  ·  Italy (7)  ·  Iran (5)  ·  Indonesia (4)  ·  Mexico (4)  ·  Thailand (4)

Top investigators

Sang Yeoup Lee, MD, PhD (6)  ·  Sang Yeoup Lee, MD (4)  ·  Chunling Jiang, PhD (3)  ·  Chia-Hua Liang, Ph.D (2)  ·  Michael Dinsmore, MD (2)  ·  Pornanong Aramwit, Professor (2)  ·  Sang Yeoup Lee (2)  ·  Abdelrady S Ibrahim, M.D. (1)  ·  Ahmad Reza Jodati, CTS (1)  ·  Ahmed Abdalla Mohamed, M.D (1)  ·  Alan P Baptist, MD (1)  ·  Aldora Jesslyn Oentari (1)  ·  Alessandra Galdino (1)  ·  Alessandra Reis, doctor (1)

Results publications

PMID 10089993, PMID 10403850, PMID 10584989, PMID 10816185, PMID 11703564, PMID 12937218, PMID 13129857, PMID 15220351, PMID 15284307, PMID 15810001, PMID 17130273, PMID 17283239, PMID 18046319, PMID 18094365, PMID 18838561, PMID 19082528, PMID 19363967, PMID 19409657, PMID 19784073, PMID 20133489, PMID 20207600, PMID 20418301, PMID 20695757, PMID 20813258, PMID 20814077, PMID 21233416, PMID 21781006, PMID 22169620, PMID 22267443, PMID 22289649, PMID 22348528, PMID 22516722, PMID 22648294, PMID 22705432, PMID 22824921, PMID 22990158, PMID 23148692, PMID 23371755, PMID 23629670, PMID 23692143, PMID 24072176, PMID 24128336, PMID 24224128, PMID 24285428, PMID 24326161, PMID 24342605, PMID 24371038, PMID 24400802, PMID 24429407, PMID 24459346

NIH funding

R01HL132448 (1)